References
- Aebischer P, Kato AC (1995). Treatment of amyotrophic lat-eral sclerosis using a gene therapy approach. Eur Neurol 35: 65–68.
- Bartlett JS, Samulski RJ, McCown TJ (1998). Selective and rapid uptake of adeno-associated virus type 2 in brain. Human Gene Ther 9: 1181–1186.
- Bilak MM, Shifrin DA, Corse AM, Bilak SR, Kuncl RW (1999). Neuroprotective utility and neurotrophic action of neurturin in postnatal motor neurons: Comparison with GDNF and persephin. Mol Cell Neurosci 13: 326–336.
- Byrnes AP, Rushy JE, Wood MJA, Charlton HM (1995). Ade-novirus gene transfer causes inflammation in the brain. Neuroscience 66: 1015–1024.
- Cashman NR, Durham HD, Blusztajn JB, ODA K, Tabira T, Shaw IT, Dahrouge S, Antel JP (1992). Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Devel Dynam 194: 209–221.
- Corse AM, Bilak MM, Bilak SR, Lehar M, Rothstein JD, Kuncl RW (1999). Preclinic al testing of neuroprotective neurotrophic factors in a model of chronic motor neuron degeneration. Neurobiol Dis 6: 335–346.
- Du B, Wu P, Boldt-Houle DM, Terwilligier EF (1996). Ef-ficient transduction of human neurons with an adeno-associated virus vector. Gene Ther 3: 254–261.
- Durbec P, Marcos-Gutierrez CV, Kilkenny C, Grigoriou M, Wartiovaara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M, Sariola H, Pachnis V (1996). GDNF sig-nalling through the ret receptor tyrosine kinase. Nature 381: 789–793.
- Haase G, Kennel P, Pettmann B, Vigne E, Akli S, Revah F, Schmalbruch H, Kahn A (1997). Gene therapy of murine motor neuron disease using adenoviral vectors for neu-rotrophic factors. Nat Med 3: 429–436.
- Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, HuZ, Cupples R, Louis J-C, Hu S, Altrock BW, Fox GM (1996). GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNF-a, a novel receptor for GDNF. Cell 85: 1113–1124.
- Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ (1994). Long term gene expres-sion and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Gen 8: 148–154.
- Keir SD, House SB, Li J, Xiao X, Gainer H (1999). Gene transfer into hypothalamic organotypic cultures using an adeno-associated virus vector. Exp Neurol 160: 313–316.
- Keir SD, Miller J, Yu G, Hamilton R, Samulski RJ, Xiao X, Tornatore C (1997). Efficient gene transfer into primary and immortalized human fetal glial cells using adeno-associated virus vectors: Establishment of a glial cell line with a functional CD4 receptor. J NeuroVirol 3: 322–330.
- Keir SD, Mitchell WJ, Feldman LT, Martin JR (1995). Target-ing and gene expression in spinal cord motor neurons following intramuscular inoculation of an HSV-1 vector. J NeuroVirol 1: 259–267.
- Keller JN, Hanni KB, Pedersen WA, Cashman NR, Mattson MP, Gabbita SP, Friebe V, MarkesberyWR (1999). Oppos-ing actions of native and oxidized lipoprotein on motor neuron-like cells. Exp Neurol 57: 202–210.
- Le Gal La Salle G, Robert JJ, Berrard S, Ridoux V, Stratford-Perricaudet M, Mallet J (1993). An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259: 988–990.
- Li L, Wu W, Lin LH, Lei M, Oppenheim RW, Houenou (1992). Rescue of adult mouse motoneurons from in-jury induced cell death by glial cell line-derived neu-rotrophic factor. Proc Nat] Acad Sci USA 92: 9771–9775.
- McCown TJ, Xiao X, Li J, Breese GR, Samulski RJ (1996). Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 713: 99–107.
- Monahan PE, Samulski RJ (2000). AAV vectors: Is clinical success on the horizon? Gene Ther 7: 24–30.
- O'Leary MT, Charlton HM (1999). A model for long-term transgene expression in spinal cord regeneration stud-ies. Gene Ther 6: 1351–1359.
- Oppenheim RW, Houenou LJ, Johnson JE, Lin L-F, Li L, Lo AC, Newsome A, Prevette DM, Wang S (1995). Developing motor neurons rescued from programmed and axotomy induced cell death by GDNF. Nature 373: 344–346.
- Pedersen WA, Cashman NR, Mattson MP (1999). The lipid peroxidation product 4 hydroxynonenal impairs glutamate and glucose transport and choline acetyl-transferase activity in NSC-19 motor neuron cells. Exp Neuro1155: 1–10.
- Peel AL, Zolotukhin S, Schrimsher GW, Muzyczka N, Reier PJ (1997). Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type specific promoters. Gene Ther 4: 16–24.
- Qing K, Mah C, Hansen J, Zhou S, Dwarki V, Srivastava A (1999). Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 5: 71–77.
- Shaw PJ (1999). Science, medicine and the future: Motor neuron disease. BMJ 318: 1118–1121.
- Summerford C, Bartlett JS, Samulski RJ (1999). aV,85 integrin: A co-receptor for adeno associated virus type 2 infection. Nat Med 5: 78–82.
- Summerford C, Samulski RJ (1998). Membrane associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. I Virol 72: 1438–1445.
- Treanor JJ, Goodman L, de Sauvage F, Stone D, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, Rosenthal A (1996). Characterization of a multicomponent receptor for GDNF. Nature 382: 80–83.
- Wood MJA, Byrnes AP, Pfaff DW, Rabkin, SD (1994). Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Gene Ther 1: 283–291.
- Xiao X, Li J, Samulski RJ (1998). Production of high titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. I Virol 72: 2224–2232.
- Yan Q, Matheson C, Lopez OT (1995). In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373: 341–344.
- Yuen EC, Mobley WC (1996). Therapeutic potential of neurotrophic factors for Neurological disorders. Ann Neurol 40: 346–354.
- Zurn AD, Baetge EE, Hammang JP, Tan SA, Aebischer P (1994). Glial cell line derived neurotrophic factor; a new neurotrophic factor for motoneurons. NeuroReport 6: 113–118.